Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.67)
# 821
Out of 4,659 analysts
377
Total ratings
54%
Success rate
18.2%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | 1,862p | +35.12% | 2 | May 26, 2026 | |
| SWX: CMHC Cosmo N.V. | Maintained: Buy | CHF 130.00 | CHF 57.30 | +126.88% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Maintained: Buy | CHF 80.00 | CHF 72.78 | +9.92% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Maintained: Buy | €5.00 | €5.88 | -14.97% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Maintained: Buy | €8.20 | €3.35 | +145.07% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | CHF 4.50 | CHF 5.84 | -22.95% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Maintained: Buy | CHF 66.00 → CHF 73.00 | CHF 54.40 | +34.19% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €85.00 | €77.04 | +10.33% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Maintained: Buy | €33.00 | €18.50 | +78.38% | 51 | Apr 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 280.00 | kr 293.50 | -4.60% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 | €13.52 | +50.15% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €36.60 | €24.56 | +49.02% | 33 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €5.00 | €2.88 | +73.61% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €15.00 | €8.02 | +87.03% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €390.00 | €330.00 | n/a | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €0.80 → €0.64 | €0.12 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $47 | $27.52 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €79.00 → €41.00 | €23.98 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $396 → $434 | $987.84 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €342.00 → €375.00 | €843.60 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.60 | n/a | 3 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 57.00 | CHF 58.00 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | €2.95 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | €3.04 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €17.00 | €4.36 | n/a | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €0.60 → €0.40 | €0.79 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €2.70 | €0.38 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €4.23 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | €105.10 | n/a | 1 | Dec 21, 2022 |
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: 1,862p
Upside: +35.12%
Cosmo N.V.
May 11, 2026
Maintained: Buy
Price Target: CHF 130.00
Current: CHF 57.30
Upside: +126.88%
Sandoz Group AG
May 11, 2026
Maintained: Buy
Price Target: CHF 80.00
Current: CHF 72.78
Upside: +9.92%
Carvolix SA
May 4, 2026
Maintained: Buy
Price Target: €5.00
Current: €5.88
Upside: -14.97%
OSE Immunotherapeutics SA
Apr 30, 2026
Maintained: Buy
Price Target: €8.20
Current: €3.35
Upside: +145.07%
Idorsia Ltd
Apr 28, 2026
Maintained: Buy
Price Target: CHF 4.50
Current: CHF 5.84
Upside: -22.95%
BB Biotech AG
Apr 24, 2026
Maintained: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: CHF 54.40
Upside: +34.19%
Sanofi
Apr 23, 2026
Maintained: Hold
Price Target: €85.00
Current: €77.04
Upside: +10.33%
Formycon AG
Apr 22, 2026
Maintained: Buy
Price Target: €33.00
Current: €18.50
Upside: +78.38%
Novo Nordisk A/S
Apr 20, 2026
Maintained: Hold
Price Target: kr 280.00
Current: kr 293.50
Upside: -4.60%
Apr 1, 2026
Maintained: Buy
Price Target: €20.30
Current: €13.52
Upside: +50.15%
Mar 6, 2026
Maintained: Buy
Price Target: €36.60
Current: €24.56
Upside: +49.02%
Feb 25, 2026
Maintained: Buy
Price Target: €5.00
Current: €2.88
Upside: +73.61%
Sep 25, 2025
Maintained: Hold
Price Target: €15.00
Current: €8.02
Upside: +87.03%
Jul 17, 2025
Maintained: Hold
Price Target: €390.00
Current: €330.00
Upside: n/a
May 6, 2024
Maintained: Sell
Price Target: €0.80 → €0.64
Current: €0.12
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $92 → $47
Current: $27.52
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: €79.00 → €41.00
Current: €23.98
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: $396 → $434
Current: $987.84
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: €342.00 → €375.00
Current: €843.60
Upside: n/a
Jan 10, 2024
Maintained: Buy
Price Target: $14
Current: $1.60
Upside: n/a
Nov 20, 2023
Maintained: Buy
Price Target: CHF 57.00
Current: CHF 58.00
Upside: n/a
Sep 7, 2023
Maintained: Buy
Price Target: €16.00
Current: €2.95
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: €3.04
Upside: n/a
Jun 22, 2023
Maintained: Buy
Price Target: €17.00
Current: €4.36
Upside: n/a
May 3, 2023
Maintained: Buy
Price Target: €0.60 → €0.40
Current: €0.79
Upside: n/a
Apr 28, 2023
Maintained: Buy
Price Target: €2.70
Current: €0.38
Upside: n/a
Dec 29, 2022
Maintained: Buy
Price Target: €12.00
Current: €4.23
Upside: n/a
Dec 21, 2022
Maintained: Buy
Price Target: €16.00
Current: €105.10
Upside: n/a